Related Experiment Video
Updated: Jul 2, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy
Justis P Ehlers1, Hasan Cetin1, Reem Amine1
1The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
Baseline ellipsoid zone (EZ) integrity predicts geographic atrophy (GA) progression. Avacincaptad pegol (ACP) treatment significantly reduced EZ loss and degradation in patients with GA over 12 months.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Biomarker Research
Background:
- Ellipsoid zone (EZ) integrity is a crucial biomarker for photoreceptor health, particularly in age-related macular degeneration (AMD).
- Spectral-domain optical coherence tomography (SD-OCT) is used to measure EZ integrity.
- Geographic atrophy (GA) is a progressive form of AMD leading to photoreceptor loss.
Purpose of the Study:
- To assess the association between baseline EZ measures and the progression of GA and photoreceptor loss.
- To evaluate the effect of avacincaptad pegol (ACP), a complement inhibitor, on EZ integrity over one year.
Main Methods:
- Post hoc analysis of pooled data from the GATHER1 and GATHER2 clinical trials.
- SD-OCT images were analyzed for EZ integrity, measuring total and partial EZ attenuation.
- GA lesion growth was tracked using fundus autofluorescence.
Main Results:
- Higher baseline EZ attenuation correlated with increased GA growth and EZ loss in sham-treated eyes.
- Avacincaptad pegol (ACP) 2 mg significantly reduced total EZ attenuation by 19.5% and partial EZ attenuation by 55.3% compared to sham over 12 months.
Conclusions:
- Baseline EZ measures are significant predictors of future GA growth and photoreceptor loss.
- ACP treatment effectively mitigated EZ loss and degradation in patients with GA.
- EZ integrity measurements can help identify high-risk patients who may benefit from early intervention.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Photoreceptors and Visual Pathways
Focusing of Light in the Eye
Diabetic Retinopathy
